This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 26 Dec 2016  |  North America

    Global Care Assistance and Automation Robots Market, Forecast to 2021

    Robot-based Hospital Automation and Augmented Quality of Care for Elderly and Disabled Offer High-yield, Early-stage Investment Opportunities for Firs

    The global care assistance and automation robots market is expected to achieve rapid adoption with a CAGR of 36% through 2021. As doctors and care providers pay more attention to patients, leaving daily tasks for the efficient handling of robotic systems, patients will receive improved quality of care and reduced hospital readmission, the prime rea...

    $4,950.00
  2. 09 Dec 2016  |  North America

    Analyst Insights from the Partners Connected Health Symposium 2016

    Moving from Technology Focus to the Human Element for Optimal Engagement and Success

    The 13th annual Partners Connected Health Symposium was held at the Boston Seaport Hotel & World Trade Center in October 2016. The key theme of the event was “Digital technology that cares. Bringing the human element to life.” The following piece presents analyst highlights, views, and major observed themes in digital health as well as company-...

    $1,500.00
  3. 30 Nov 2016  |  North America

    Third Party Sterilization Services for Care Providers in the US and Western Europe, Forecast to 2022

    Hospitals are Increasingly Outsourcing their Surgical Instrument Sterilization - Next Frontier for Disinfection and Sterilization Equipment OEM?

    The study covers current and future market trends, drivers, and challenges in outsourcing of hospital sterile processing departments (SPD)/central sterile supply departments (CSSD) to specialized third party vendors. Despite being in the nascent phase, the third party sterilization services market generated total revenue of $1.4 billion in 2015 and...

    $4,950.00
  4. 16 Nov 2016  |  North America

    Analysis of the Global Cardiac Monitoring Products Market

    Better Technology at Lower Costs Pave Way for Market Recovery

    This research service presents a global analysis of the cardiac monitoring products market. Market participants were interviewed to obtain their perceptions of cardiac monitoring products and trends. As a result, this study provides an in-depth analysis of the current trends, market size, revenue forecast, and drivers and restraints. It also assess...

    $4,950.00
  5. 15 Nov 2016  |  North America

    Healthcare 2020—Business Model Transformation Guidebook

    Exploring New Models for Monetizing Services and Solutions

    Healthcare as an industry is entering a phase of rapid transformation. Digitization of products, services, and commerce models are democratizing current healthcare systems and unlocking new values by displacing high-cost gatekeepers and previously inaccessible segments. Around 80% of the business models in 2025 will be driven by platform-based heal...

    $4,950.00
  6. 11 Nov 2016  |  North America

    Global Analysis of the Neonatal (Preterm) Care Equipment Market

    A Holistic Approach to Preterm Health and Wellbeing

    The neonatal devices market will continue to be shaped by the regional and local trends in the annual live births and infrastructure market. The industry is undergoing changes in regards to regulatory protocols, preventive care, reimbursement models, healthcare digitization, patient interests, physician preferences, and executive priorities. Stakeh...

    $4,950.00
  7. 11 Nov 2016  |  North America

    Global Orphan Drug Market

    High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs

    The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

    $6,000.00
  8. 09 Nov 2016  |  North America

    US Robotic-assisted Surgery Market, 2016

    As a Third Generation of Technology Emerges, Where is the Market Headed?

    This research traces the history of the first clinical applications for robotic devices and all associated technology required to create a true robotic-assisted surgical device (RASD). The study examines the people (leaders) and entities that became pioneers and founders of the RASD industry vertical. With fundamental original equipment manufacture...

    $4,950.00
  9. 09 Nov 2016  |  North America

    New Paradigms Driving Digital Health Deals and Partnerships

    Healthcare Transformation and Industry Convergence

    Digital technologies are critical enablers of healthcare transformation but organizations vary greatly in their capabilities to deliver new solutions needed to capture growing market opportunities. The imperative to rapidly bring on new IT capabilities as well as to continually adapt and innovate in a highly dynamic environment is driving a wide ar...

    $1,500.00
  10. 08 Nov 2016  |  North America

    The US Molecular Diagnostics Market, Forecast to 2021

    Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye

    The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

    $4,950.00